KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 121 filers reported holding KALA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $124,000 | -27.9% | 557,962 | -2.5% | 0.00% | – |
| Q2 2022 | $172,000 | +149.3% | 572,189 | +1044.4% | 0.00% | – |
| Q1 2022 | $69,000 | -9.2% | 50,000 | -20.5% | 0.00% | – |
| Q4 2021 | $76,000 | -81.0% | 62,872 | -59.0% | 0.00% | – |
| Q3 2021 | $401,000 | +167.3% | 153,211 | +439.8% | 0.00% | – |
| Q2 2021 | $150,000 | -96.8% | 28,381 | -95.9% | 0.00% | -100.0% |
| Q1 2021 | $4,723,000 | -15.8% | 700,675 | -15.3% | 0.00% | -25.0% |
| Q4 2020 | $5,606,000 | +158.7% | 826,903 | +186.2% | 0.00% | +33.3% |
| Q3 2020 | $2,167,000 | -47.9% | 288,931 | -27.0% | 0.00% | -50.0% |
| Q2 2020 | $4,160,000 | -43.8% | 395,824 | -53.0% | 0.01% | -64.7% |
| Q1 2020 | $7,400,000 | +265.6% | 841,853 | +53.5% | 0.02% | +466.7% |
| Q4 2019 | $2,024,000 | -5.0% | 548,470 | -2.1% | 0.00% | 0.0% |
| Q3 2019 | $2,131,000 | -41.3% | 560,121 | -1.5% | 0.00% | -40.0% |
| Q2 2019 | $3,628,000 | -45.5% | 568,601 | -29.4% | 0.01% | -50.0% |
| Q1 2019 | $6,656,000 | +745.7% | 804,826 | +399.8% | 0.01% | +900.0% |
| Q4 2018 | $787,000 | -79.7% | 161,041 | -59.0% | 0.00% | -80.0% |
| Q3 2018 | $3,875,000 | -52.9% | 392,642 | -34.4% | 0.01% | -54.5% |
| Q2 2018 | $8,224,000 | -48.0% | 598,950 | -40.0% | 0.01% | -47.6% |
| Q1 2018 | $15,803,000 | +726.5% | 998,319 | +865.5% | 0.02% | +600.0% |
| Q4 2017 | $1,912,000 | +35.5% | 103,400 | +67.4% | 0.00% | +50.0% |
| Q3 2017 | $1,411,000 | – | 61,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |